Sep 28, 2021 7:00 am EDT Castle Biosciences President and CEO Derek Maetzold Will Deliver Keynote Presentation During Arizona Bioscience Week
Sep 16, 2021 7:00 am EDT Castle Biosciences Announces New York Approval of DecisionDx® DiffDx™-Melanoma
Aug 30, 2021 7:00 am EDT Castle Biosciences Recognized as a Top 100 Healthcare Technology Company of 2021
Aug 24, 2021 7:00 am EDT Castle Biosciences Awarded U.S. Federal Supply Schedule Contract for DecisionDx-Melanoma
Aug 16, 2021 7:00 am EDT Castle Biosciences Presents New Data on DecisionDx®-Melanoma and DecisionDx®-SCC at the 2021 American Academy of Dermatology (AAD) Summer Meeting
Aug 6, 2021 7:00 am EDT Castle Biosciences to Present Data at the 2021 American Academy of Dermatology (AAD) Summer Meeting
Aug 5, 2021 7:00 am EDT Castle Biosciences Presents Data on DecisionDx®-Melanoma and DecisionDx®-SCC at the DERM2021 NP/PA CME Conference
